NovoCure
NVCR
NVCR
241 hedge funds and large institutions have $1.68B invested in NovoCure in 2025 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 85 increasing their positions, 71 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less capital invested
Capital invested by funds: $1.7B → $1.68B (-$14.8M)
1.87% less ownership
Funds ownership: 86.6% → 84.73% (-1.9%)
Holders
241
Holding in Top 10
2
Calls
$21.2M
Puts
$3.53M
Top Buyers
| 1 | +$24.6M | |
| 2 | +$20.8M | |
| 3 | +$19.3M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$17.1M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$12.8M |
Top Sellers
| 1 | -$159M | |
| 2 | -$10.8M | |
| 3 | -$8.88M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$7.31M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$7M |
